Commission Catalyst: Vyome Holdings Battle Card

🚀 Battle Card: Vyome Holdings, Inc.

• Dr. Richard Fahrner, Chief Technology Officer · 🔗 LinkedIn

• Dr. Tamara Agajanov, Senior Vice President – Clinical Development · 🔗 LinkedIn

• Bolstering R&D and clinical ops expertise positions them to hit pivotal trial milestones faster. Use this Vyome Holdings, Inc. sales trigger to drive urgency. → Source

• Need to accelerate trial design and approvals ahead of Phase 2 topline

• Build investor confidence with seasoned leadership

• Primary: Clinical trial optimization platform → Faster FDA submission cycles

• Expansion: Regulatory intelligence services → Improved accelerated approval success

• HQ: Cambridge, MA

• Employees: ≈ 80

• Rev: ≈ $5 M

• Website: vyometx.com

🤼 Competitive Intel

• Veeva Systems — CTMS / Regulatory
• Unique edge: Industry-standard trial and compliance tools
• Evaluated by CTO & SVP Clinical Dev for unified data management

• Medidata — Clinical Trial Design / EDC
• Unique edge: Advanced analytics and eCOA integrations
• Reviewed by Clinical Dev for patient-centric endpoints

• Parexel — CRO / Regulatory Consulting
• Unique edge: End-to-end trial management and accelerated approval support
• Scoped by CTO for streamlined FDA pathways

• IQVIA — Data Analytics / CRO
• Unique edge: Real-world evidence and global study reach
• Considered by Ops for scaling Phase 2 to pivotal

✅ Do-Now Checklist

Next Step

🧠 Copy My Prompt for Personalized Cold Outreach

────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY   = ❑❑
OFFER_BRIEF   = ❑Clinical trial optimization platform that accelerates FDA submissions by 40%❑
PROOF_METRIC  = ❑40% faster approvals❑
CTA_STYLE     = ❑quick_call❑
TONE          = ❑friendly❑

────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME        = Dr. Richard
COMPANY     = Vyome Holdings, Inc.
DEPT        = Clinical Development
SIZE        = ≈20
BOTTLENECK  = slow trial design and FDA submissions
EVENT       = Strengthened leadership with veteran CTO & SVP Clinical Dev
DETAIL      = leadership team strengthened with industry veterans
PAIN        = slow trial approvals delaying pivotal studies
SRC         = http://cts.businesswire.com/ct/CT?id=ftfLlWd9aZbF2NXfwppam3Bd664=&newsLang=en&newsId=20250909508635&div=41152219
SIM_CO      = Biogen
WIN_METRIC  = 40% faster approvals
NEXT_SIZE   = ≈50
EMP_EST     = ≈80 employees
REV_EST     = ≈$5M

────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”.

Validate any ≈ guesses via SRC.

EMAIL  (keep breaks):
Subject: ≈20-person Clinical Development

Dr. Richard—noticed your Clinical Development team is ≈20.

That’s when slow trial design and FDA submissions slows growth.

We helped Biogen fix this with Clinical trial optimization platform that accelerates FDA submissions by 40%.

Result: 40% faster approvals.  
Quick call?

PS—next bottleneck hits ≈50.

DM ≤45 words, TONE:
Saw your post about leadership team strengthened with industry veterans — slow trial approvals delaying pivotal studies.  
Clinical trial optimization platform that accelerates FDA submissions by 40%. 40% faster approvals.  
Quick chat?```